As of Oct 19
| +0.30 / +14.29%|
The 1 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +108.33% increase from the last price of 2.40.
The current consensus among 4 polled investment analysts is to Hold stock in Infinity Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.